Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs
Orphazyme A/S (NASDAQ: ORPH) has
The Daily Biotech Pulse: Merck’s Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.
64 Biggest Movers From Yesterday
Gainers
Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co.
31 Stocks Moving In Thursday’s Mid-Day Session
Gainers
TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results.
94 Biggest Movers From Friday
Gainers
Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday.
TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.
Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Orphazyme Shares Plunge
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq dropping 150 points on Friday.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows.